Outcomes in radiotherapy-treated patients with cancer during COVID-19

What The Study Did: The delivery of radiotherapy in 209 patients with cancer during the COVID-19 outbreak in Wuhan, China, is evaluated in this case series.

Authors: Conghua Xie, M.D., Ph.D., of Zhongnan Hospital of Wuhan University in Wuhan, China, and Melvin L. K. Chua, M.B.B.S., Ph.D., of the National Cancer Centre Singapore in Singapore, are the corresponding authors.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaoncol.2020.2783)

Editor's Note: The article contains funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.2783?guestAccessKey=9ebb15f2-1545-427b-aaa5-5aef96a54f27&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=073020

Credit: 
JAMA Network